Question 1

Does Geode Capital Management own AIM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Geode Capital Management holds 46,003 shares of AIM (Aim Immunotech), worth $13,064.

Question 2

How many shares of AIM does Geode Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Geode Capital Management holds 46,003 shares of AIM (Aim Immunotech).

Question 3

What is Geode Capital Management's AIM position worth?

Accepted Answer

As of its Q2 2026 13F, Geode Capital Management's AIM position is worth $13,064.

Question 4

Is Geode Capital Management buying or selling AIM?

Accepted Answer

In Q2 2026, Geode Capital Management increased its AIM position by 16,085 shares (+53.8%).

Question 5

When did Geode Capital Management first buy AIM?

Accepted Answer

Geode Capital Management first reported AIM in its Q3 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	46,003	+53.8%	$13,064	0.0%	$0.28	17
2026-Q1	Increased	29,918	+72.2%	$17,501	0.0%	$0.70	19
2025-Q4	Increased	17,376	+7.3%	$19,634	0.0%	$1.22	14
2025-Q3	New	16,186	-	$44,349	0.0%	$2.66	31

AIM4 quarters

AIM
4 quarters